Annual Current Assets
$341.53 M
+$279.27 M+448.57%
31 December 2023
Summary:
Spyre Therapeutics annual total current assets is currently $341.53 million, with the most recent change of +$279.27 million (+448.57%) on 31 December 2023. During the last 3 years, it has risen by +$242.64 million (+245.36%). SYRE annual current assets is now at all-time high.SYRE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$421.08 M
-$14.66 M-3.36%
30 September 2024
Summary:
Spyre Therapeutics quarterly total current assets is currently $421.08 million, with the most recent change of -$14.66 million (-3.36%) on 30 September 2024. Over the past year, it has increased by +$79.55 million (+23.29%). SYRE quarterly current assets is now -13.58% below its all-time high of $487.27 million, reached on 31 March 2024.SYRE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +23.3% |
| 3 y3 years | +245.4% | +325.8% |
| 5 y5 years | +358.4% | +465.2% |
SYRE Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +448.6% | -13.6% | +848.9% |
| 5 y | 5 years | at high | +448.6% | -13.6% | +848.9% |
| alltime | all time | at high | >+9999.0% | -13.6% | >+9999.0% |
Spyre Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $421.08 M(-3.4%) |
| June 2024 | - | $435.74 M(-10.6%) |
| Mar 2024 | - | $487.27 M(+42.7%) |
| Dec 2023 | $331.00 K(-96.3%) | $341.53 M(+65.8%) |
| Sept 2023 | - | $205.95 M(-14.1%) |
| June 2023 | - | $239.89 M(+440.6%) |
| Mar 2023 | - | $44.38 M(-28.7%) |
| Dec 2022 | $8.89 M(-19.5%) | - |
| Dec 2022 | - | $62.26 M(-24.3%) |
| Sept 2022 | - | $82.22 M(-14.9%) |
| June 2022 | - | $96.65 M(+33.1%) |
| Mar 2022 | - | $72.60 M(-26.6%) |
| Dec 2021 | $11.04 M(-6.7%) | $98.89 M(-15.8%) |
| Sept 2021 | - | $117.51 M(-12.5%) |
| June 2021 | - | $134.37 M(-11.3%) |
| Mar 2021 | - | $151.41 M(+1.1%) |
| Dec 2020 | $11.83 M(+36.3%) | $149.79 M(+3.7%) |
| Sept 2020 | - | $144.40 M(-10.8%) |
| June 2020 | - | $161.87 M(+198.3%) |
| Mar 2020 | - | $54.27 M(-27.2%) |
| Dec 2019 | $8.68 M | $74.50 M(-19.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $92.63 M(-15.7%) |
| June 2019 | - | $109.94 M(-13.3%) |
| Mar 2019 | - | $126.82 M(+65.4%) |
| Dec 2018 | $1.07 M(-1.7%) | $76.67 M(+8.9%) |
| Sept 2018 | - | $70.38 M(-10.8%) |
| June 2018 | - | $78.89 M(+61.5%) |
| Mar 2018 | - | $48.84 M(-11.2%) |
| Dec 2017 | $1.09 M(+70.0%) | $54.99 M(-7.6%) |
| Sept 2017 | - | $59.52 M(-10.1%) |
| June 2017 | - | $66.20 M(+9.8%) |
| Mar 2017 | - | $60.30 M(-9.2%) |
| Dec 2016 | $639.00 K(+73.6%) | $66.42 M(-7.3%) |
| Sept 2016 | - | $71.68 M(-6.8%) |
| June 2016 | - | $76.91 M(+118.5%) |
| Mar 2016 | - | $35.20 M(-8.0%) |
| Dec 2015 | $368.00 K(+84.0%) | $38.29 M(-8.2%) |
| Sept 2015 | - | $41.73 M(-8.0%) |
| June 2015 | - | $45.38 M(+2.9%) |
| Mar 2015 | - | $44.09 M(+1515.2%) |
| Dec 2014 | $200.00 K(>+9900.0%) | $2.73 M |
| Dec 2013 | $0.00 | - |
FAQ
- What is Spyre Therapeutics annual total current assets?
- What is the all time high annual current assets for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly current assets year-on-year change?
What is Spyre Therapeutics annual total current assets?
The current annual current assets of SYRE is $341.53 M
What is the all time high annual current assets for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total current assets is $341.53 M
What is Spyre Therapeutics quarterly total current assets?
The current quarterly current assets of SYRE is $421.08 M
What is the all time high quarterly current assets for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total current assets is $487.27 M
What is Spyre Therapeutics quarterly current assets year-on-year change?
Over the past year, SYRE quarterly total current assets has changed by +$79.55 M (+23.29%)